18,470 Shares in Zoetis Inc. $ZTS Purchased by GSA Capital Partners LLP

Key Points

• GSA Capital Partners LLP bought 18,470 Zoetis shares during the second quarter, valued at approximately $1.33 million. Institutional investors and hedge funds collectively own 92.8% of the company.
• Analyst sentiment is mixed, with eight Buy, nine Hold, and two Sell ratings. Zoetis has an average rating of Hold and an average price target of $109.62, although several analysts recently lowered their targets.
• Zoetis reported quarterly EPS of $1.87, slightly above estimates, while revenue declined 0.2% year over year to $2.47 billion. The company also declared a quarterly dividend of $0.53 per share, representing a 2.9% annualized yield.

GSA Capital Partners LLP bought a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 18,470 shares of the company's stock, valued at approximately $1,327,000.

A number of other large investors have also recently bought and sold shares of the company. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Zoetis in the second quarter worth $25,000. Prosperity Bancshares Inc bought a new position in Zoetis in the fourth quarter valued at $25,000. Cassaday & Co Wealth Management LLC acquired a new stake in Zoetis in the 1st quarter valued at $28,000. Root Financial Partners LLC lifted its position in Zoetis by 66.5% during the 1st quarter. Root Financial Partners LLC now owns 258 shares of the company's stock worth $30,000 after buying an additional 103 shares in the last quarter. Finally, Elyxium Wealth LLC bought a new stake in Zoetis during the 4th quarter worth about $32,000. Institutional investors and hedge funds own 92.80% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Citigroup lowered their target price on Zoetis from $112.00 to $96.00 and set a "buy" rating on the stock in a research report on Tuesday, August 11th. Piper Sandler decreased their price target on Zoetis from $90.00 to $80.00 and set a "neutral" rating for the company in a research note on Monday, August 10th. William Blair reiterated a "market perform" rating on shares of Zoetis in a research note on Thursday, August 6th. Wall Street Zen downgraded Zoetis from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Finally, Morgan Stanley set a $85.00 target price on shares of Zoetis in a report on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $109.62.

Zoetis Stock Down 1.5%

ZTS opened at $72.71 on Tuesday. The stock's fifty day simple moving average is $76.17 and its 200 day simple moving average is $98.47. Zoetis Inc. has a 1-year low of $71.00 and a 1-year high of $160.48. The stock has a market cap of $30.05 billion, a PE ratio of 11.98, a price-to-earnings-growth ratio of 1.28 and a beta of 0.73. The company has a current ratio of 3.08, a quick ratio of 1.84 and a debt-to-equity ratio of 2.87.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.87 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.02. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The firm had revenue of $2.47 billion during the quarter, compared to analysts' expectations of $2.50 billion. During the same period in the previous year, the business posted $1.76 earnings per share. The company's revenue for the quarter was down .2% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, research analysts expect that Zoetis Inc. will post 6.19 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Monday, July 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.9%. Zoetis's payout ratio is presently 34.93%.

Zoetis Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source